Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain

Mechanisms of Ageing and Development

Volumn 161, Issue , 2017, Pages 95-104

  Abolhassani, Nona ^a   Leon, Julio ^a   Sheng, Zijing ^a   Oka, Sugako ^a   Hamasaki, Hideomi ^b   Iwaki, Toru ^b   Nakabeppu, Yusaku ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

8 Oxoguanine; Alzheimer's disease; Glucose metabolism; Mitochondrial dysfunction; Oxidative DNA damage

Indexed keywords

8 HYDROXYGUANINE; ANTIOXIDANT; CELL NUCLEUS DNA; DNA GLYCOSYLASE MUTY; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; DNA GLYCOSYLTRANSFERASE; GLUCOSE; OXOGUANINE GLYCOSYLASE 1, HUMAN;

ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; COGNITIVE DEFECT; DEMENTIA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; GLUCOSE METABOLISM; HUMAN; IN VITRO STUDY; INSULIN RESISTANCE; MITOCHONDRIAL DYSFUNCTION; MOLECULAR PATHOLOGY; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; BRAIN CORTEX; GENETICS; METABOLISM; MITOCHONDRION; PATHOLOGY; PATHOPHYSIOLOGY;

ALZHEIMER DISEASE; CEREBRAL CORTEX; DNA DAMAGE; DNA GLYCOSYLASES; DNA, MITOCHONDRIAL; GLUCOSE; HUMANS; MITOCHONDRIA;

EID: 84971602504     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2016.05.005     Document Type: Article

References (119)

1. Aliev, G., Seyidova, D., Lamb, B.T., Obrenovich, M.E., Siedlak, S.L., Vinters, H.V., Friedland, R.P., LaManna, J.C., Smith, M.A., Perry, G., Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurol. Res. 25 (2003), 665–674.
2. Alzheimer's Association, 2015 Alzheimer's disease facts and figures. Alzheimers Dement. 11 (2015), 332–384.
3. Bateman, R.J., Xiong, C., Benzinger, T.L., Fagan, A.M., Goate, A., Fox, N.C., Marcus, D.S., Cairns, N.J., Xie, X., Blazey, T.M., Holtzman, D.M., Santacruz, A., Buckles, V., Oliver, A., Moulder, K., Aisen, P.S., Ghetti, B., Klunk, W.E., McDade, E., Martins, R.N., Masters, C.L., Mayeux, R., Ringman, J.M., Rossor, M.N., Schofield, P.R., Sperling, R.A., Salloway, S., Morris, J.C., Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367 (2012), 795–804.
4. Bedse, G., Di Domenico, F., Serviddio, G., Cassano, T., Aberrant insulin signaling in Alzheimer's disease: current knowledge. Front. Neurosci., 9, 2015, 204.
5. Belanger, M., Allaman, I., Magistretti, P.J., Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14 (2011), 724–738.
6. Benedict, C., Hallschmid, M., Schultes, B., Born, J., Kern, W., Intranasal insulin to improve memory function in humans. Neuroendocrinology 86 (2007), 136–142.
7. Bezzi, P., Volterra, A., Astrocytes: powering memory. Cell 144 (2011), 644–645.
8. Bhat, A.H., Dar, K.B., Anees, S., Zargar, M.A., Masood, A., Sofi, M.A., Ganie, S.A., Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed. Pharmacother. 74 (2015), 101–110.
9. Bo, H., Kang, W., Jiang, N., Wang, X., Zhang, Y., Ji, L.L., Exercise-induced neuroprotection of hippocampus in APP/PS1 transgenic mice via upregulation of mitochondrial 8-oxoguanine DNA glycosylase. Oxid. Med. Cell. Longevity, 2014, 2014, 834502.
10. Boiteux, S., Radicella, J.P., The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch. Biochem. Biophys. 377 (2000), 1–8.
11. Bossers, K., Wirz, K.T., Meerhoff, G.F., Essing, A.H., van Dongen, J.W., Houba, P., Kruse, C.G., Verhaagen, J., Swaab, D.F., Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain 133 (2010), 3699–3723.
12. Bradley-Whitman, M.A., Timmons, M.D., Beckett, T.L., Murphy, M.P., Lynn, B.C., Lovell, M.A., Nucleic acid oxidation: an early feature of Alzheimer's disease. J. Neurochem. 128 (2014), 294–304.
13. Brooks, W.M., Lynch, P.J., Ingle, C.C., Hatton, A., Emson, P.C., Faull, R.L., Starkey, M.P., Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res. 1127 (2007), 127–135.
14. Bullon, P., Newman, H.N., Battino, M., Obesity, diabetes mellitus, atherosclerosis and chronic periodontitits: a shared pathology via oxidative stress and mitochondrial dysfunction?. Periodontol 2000:64 (2014), 139–153.
15. Cardozo-Pelaez, F., Sanchez-Contreras, M., Nevin, A.B., Ogg1 null mice exhibit age-associated loss of the nigrostriatal pathway and increased sensitivity to MPTP. Neurochem. Int. 61 (2012), 721–730.
16. Cerami, C., Della Rosa, P.A., Magnani, G., Santangelo, R., Marcone, A., Cappa, S.F., Perani, D., Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia. Neuroimage Clin. 7 (2015), 187–194.
17. Chen, Z., Zhong, C., Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog. Neurobiol. 108 (2013), 21–43.
18. Cheng, Z., Guo, S., Copps, K., Dong, X., Kollipara, R., Rodgers, J.T., Depinho, R.A., Puigserver, P., White, M.F., Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat. Med. 15 (2009), 1307–1311.
19. Cheng, Z., Tseng, Y., White, M.F., Insulin signaling meets mitochondria in metabolism. Trends Endocrinol. Metab. 21 (2010), 589–598.
20. Cobb, C.A., Cole, M.P., Oxidative and nitrative stress in neurodegeneration. Neurobiol. Dis. 84 (2015), 4–21.
21. Colangelo, V., Schurr, J., Ball, M.J., Pelaez, R.P., Bazan, N.G., Lukiw, W.J., Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70 (2002), 462–473.
22. Coppede, F., Migliore, L., DNA damage in neurodegenerative diseases. Mutat. Res. 776 (2015), 84–97.
23. Craft, S., Stennis Watson, G., Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 3 (2004), 169–178.
24. Cunnane, S., Nugent, S., Roy, M., Courchesne-Loyer, A., Croteau, E., Tremblay, S., Castellano, A., Pifferi, F., Bocti, C., Paquet, N., Begdouri, H., Bentourkia, M., Turcotte, E., Allard, M., Barberger-Gateau, P., Fulop, T., Rapoport, S.I., Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 27 (2011), 3–20.
25. De Luca, G., Russo, M.T., Degan, P., Tiveron, C., Zijno, A., Meccia, E., Ventura, I., Mattei, E., Nakabeppu, Y., Crescenzi, M., Pepponi, R., Pezzola, A., Popoli, P., Bignami, M., A role for oxidized DNA precursors in Huntington's disease-like striatal neurodegeneration. PLoS Genet., 4, 2008, e1000266.
26. de la Monte, S.M., Luong, T., Neely, T.R., Robinson, D., Wands, J.R., Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab. Invest. 80 (2000), 1323–1335.
27. de la Monte, S.M., Type 3 diabetes is sporadic Alzheimers disease: mini-review. Eur. Neuropsychopharmacol. 24 (2014), 1954–1960.
28. Dong, X.C., Copps, K.D., Guo, S., Li, Y., Kollipara, R., DePinho, R.A., White, M.F., Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab. 8 (2008), 65–76.
29. Duelli, R., Kuschinsky, W., Brain glucose transporters: relationship to local energy demand. News Physiol. Sci. 16 (2001), 71–76.
30. 2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease. Neuroscience 228 (2013), 294–300.
31. Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., Schroeter, M.L., Alzheimer's Disease Neuroimaging, I., Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease. Neuroimage Clin. 3 (2013), 84–94.
32. Eckert, A., Schmitt, K., Gotz, J., Mitochondrial dysfunction—the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity. Alzheimers Res. Ther., 3, 2011, 15.
33. Fafalios, A., Ma, J., Tan, X., Stoops, J., Luo, J., Defrances, M.C., Zarnegar, R., A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat. Med. 17 (2011), 1577–1584.
34. Fowler, K.D., Funt, J.M., Artyomov, M.N., Zeskind, B., Kolitz, S.E., Towfic, F., Leveraging existing data sets to generate new insights into Alzheimer's disease biology in specific patient subsets. Sci. Rep., 5, 2015, 14324.
35. Furuta, A., Iida, T., Nakabeppu, Y., Iwaki, T., Expression of hMTH1 in the hippocampi of control and Alzheimer's disease. Neuroreport 12 (2001), 2895–2899.
36. Gabbita, S.P., Lovell, M.A., Markesbery, W.R., Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71 (1998), 2034–2040.
37. Garwood, C.J., Ratcliffe, L.E., Morgan, S.V., Simpson, J.E., Owens, H., Vazquez-Villasenor, I., Heath, P.R., Romero, I.A., Ince, P.G., Wharton, S.B., Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors. Mol. Brain, 8, 2015, 51.
38. Gerritsen, M.E., Tomlinson, J.E., Zlot, C., Ziman, M., Hwang, S., Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br. J. Pharmacol. 140 (2003), 595–610.
39. Ghasemi, R., Haeri, A., Dargahi, L., Mohamed, Z., Ahmadiani, A., Insulin in the brain: sources, localization and functions. Mol. Neurobiol. 47 (2013), 145–171.
40. Gotz, J., Ittner, A., Ittner, L.M., Tau-targeted treatment strategies in Alzheimer's disease. Br. J. Pharmacol. 165 (2012), 1246–1259.
41. Gray, S.M., Meijer, R.I., Barrett, E.J., Insulin regulates brain function, but how does it get there?. Diabetes 63 (2014), 3992–3997.
42. Grillo, C.A., Piroli, G.G., Hendry, R.M., Reagan, L.P., Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res. 1296 (2009), 35–45.
43. Gross, D.N., van den Heuvel, A.P., Birnbaum, M.J., The role of FoxO in the regulation of metabolism. Oncogene 27 (2008), 2320–2336.
44. Guo, S., Copps, K.D., Dong, X., Park, S., Cheng, Z., Pocai, A., Rossetti, L., Sajan, M., Farese, R.V., White, M.F., The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Mol. Cell. Biol. 29 (2009), 5070–5083.
45. Haass, C., Steiner, H., Alheimer disease gamma-secretase: a complex story of GxGD-ype presenilin proteases. Trends Cell Biol. 12 (2002), 556–562.
46. Hamasaki, H., Honda, H., Suzuki, S.O., Hokama, M., Kiyohara, Y., Nakabeppu, Y., Iwaki, T., Down-regulation of MET in hippocampal neurons of Alzheimer's disease brains. Neuropathology 34 (2014), 284–290.
47. Hao, K., Di Narzo, A.F., Ho, L., Luo, W., Li, S., Chen, R., Li, T., Dubner, L., Pasinetti, G.M., Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes. Mol. Aspects Med. 43–44 (2015), 66–76.
48. Havrankova, J., Roth, J., Brownstein, M.J., Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents. J. Clin. Invest. 64 (1979), 636–642.
49. Heni, M., Hennige, A.M., Peter, A., Siegel-Axel, D., Ordelheide, A.M., Krebs, N., Machicao, F., Fritsche, A., Haring, H.U., Staiger, H., Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS One, 6, 2011, e21594.
50. Hokama, M., Oka, S., Leon, J., Ninomiya, T., Honda, H., Sasaki, K., Iwaki, T., Ohara, T., Sasaki, T., LaFerla, F.M., Kiyohara, Y., Nakabeppu, Y., Altered expression of diabetes-related genes in Alzheimer's disease brains: the hisayama study. Cereb. Cortex 24 (2014), 2476–2488.
51. Iida, T., Furuta, A., Nishioka, K., Nakabeppu, Y., Iwaki, T., Expression of 8-oxoguanine DNA glycosylase is reduced and associated with neurofibrillary tangles in Alzheimer's disease brain. Acta Neuropathol. 103 (2002), 20–25.
52. Jacob, K.D., Noren Hooten, N., Tadokoro, T., Lohani, A., Barnes, J., Evans, M.K., Alzheimer's disease-associated polymorphisms in human OGG1 alter catalytic activity and sensitize cells to DNA damage. Free Radic. Biol. Med. 63 (2013), 115–125.
53. Jurcovicova, J., Glucose transport in brain—effect of inflammation. Endocr. Regul. 48 (2014), 35–48.
54. Kang, J., Lemaire, H., Unterbeck, A., J.M, S., C.L, M., Grzeschik, K., Multhaup, G., Beyreuther, K., Muller-Hill, B., The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987), 733–736.
55. Kauppinen, T.M., Swanson, R.A., The role of poly(ADP-ribose) polymerase-1 in CNS disease. Neuroscience 145 (2007), 1267–1272.
56. Kleinridders, A., Ferris, H.A., Cai, W., Kahn, C.R., Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63 (2014), 2232–2243.
57. Kleinridders, A., Cai, W., Cappellucci, L., Ghazarian, A., Collins, W.R., Vienberg, S.G., Pothos, E.N., Kahn, C.R., Insulin resistance in brain alters dopamine turnover and causes behavioral disorders. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 3463–3468.
58. Kuwabara, T., Kagalwala, M.N., Onuma, Y., Ito, Y., Warashina, M., Terashima, K., Sanosaka, T., Nakashima, K., Gage, F.H., Asashima, M., Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. EMBO Mol. Med. 3 (2011), 742–754.
59. Leon, J., Sakumi, K., Castillo, E., Sheng, Z., Oka, S., Nakabeppu, Y., 8-Oxoguanine accumulation in mitochondrial DNA causes mitochondrial dysfunction and impairs neuritogenesis in cultured adult mouse cortical neurons under oxidative conditions. Sci. Rep., 6, 2016, 22086.
60. Lillenes, M.S., Stoen, M., Gomez-Munoz, M., Torp, R., Gunther, C.C., Nilsson, L.N., Tonjum, T., Transient OGG1, APE1, PARP1 and Polβ expression in an Alzheimer's disease mouse model. Mech. Ageing Dev. 134 (2013), 467–477.
61. Liu, D., Croteau, D.L., Souza-Pinto, N., Pitta, M., Tian, J., Wu, C., Jiang, H., Mustafa, K., Keijzers, G., Bohr, V.A., Mattson, M.P., Evidence that OGG1 glycosylase protects neurons against oxidative DNA damage and cell death under ischemic conditions. J. Cereb. Blood Flow Metab. 31 (2011), 680–692.
62. Lovell, M.A., Markesbery, W.R., Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 35 (2007), 7497–7504.
63. Lovell, M.A., Soman, S., Bradley, M.A., Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech. Ageing Dev. 132 (2011), 443–448.
64. Lyras, L., Cairns, N.J., Jenner, A., Jenner, P., Halliwell, B., An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68 (1997), 2061–2069.
65. MacKenna, M., Dienel, G., HS, W., A, S., Energy metaboilsm of the brain. Brady, S., Siegel, G., (eds.) Basic. Neurochemistry, 8th ed., 2012, Academic Press Waltham, MA, USA, 200–231.
66. Mao, G., Pan, X., Zhu, B.B., Zhang, Y., Yuan, F., Huang, J., Lovell, M.A., Lee, M.P., Markesbery, W.R., Li, G.M., Gu, L., Identification and characterization of OGG1 mutations in patients with Alzheimer's disease. Nucleic Acids Res. 35 (2007), 2759–2766.
67. Martire, S., Mosca, L., d'Erme, M., PARP-1 involvement in neurodegeneration: a focus on Alzheimer's and Parkinson's diseases. Mech. Ageing Dev. 146–148 (2015), 53–64.
68. Maruszak, A., Zekanowski, C., Mitochondrial dysfunction and Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 35 (2011), 320–330.
69. Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., Sekita, A., Suzuki, S., Kanba, S., Kiyohara, Y., Iwaki, T., Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama Study. Neurology 75 (2010), 764–770.
70. Mecocci, P., MacGarvey, U., Beal, M.F., Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36 (1994), 747–751.
71. Mehran, A.E., Templeman, N.M., Brigidi, G.S., Lim, G.E., Chu, K.Y., Hu, X., Botezelli, J.D., Asadi, A., Hoffman, B.G., Kieffer, T.J., Bamji, S.X., Clee, S.M., Johnson, J.D., Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 16 (2012), 723–737.
72. Miele, C., Rochford, J.J., Filippa, N., Giorgetti-Peraldi, S., Van Obberghen, E., Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J. Biol. Chem. 275 (2000), 21695–21702.
73. Miller-Pinsler, L., Pinto, D.J., Wells, P.G., Oxidative DNA damage in the in utero initiation of postnatal neurodevelopmental deficits by normal fetal and ethanol-enhanced oxidative stress in oxoguanine glycosylase 1 knockout mice. Free Radic. Biol. Med. 78 (2015), 23–29.
74. Molnar, G., Farago, N., Kocsis, A.K., Rozsa, M., Lovas, S., Boldog, E., Baldi, R., Csajbok, E., Gardi, J., Puskas, L.G., Tamas, G., GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex. J. Neurosci. 34 (2014), 1133–1137.
75. Mosconi, L., Murray, J., Tsui, W.H., Li, Y., Spector, N., Goldowsky, A., Williams, S., Osorio, R., McHugh, P., Glodzik, L., Vallabhajosula, S., de Leon, M.J., Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD. Neurology 82 (2014), 752–760.
76. Muhic, M., Vardjan, N., Chowdhury, H.H., Zorec, R., Kreft, M., Insulin and insulin-like growth factor 1 (IGF-1) modulate cytoplasmic glucose and glycogen levels but not glucose transport across the membrane in astrocytes. J. Biol. Chem. 290 (2015), 11167–11176.
77. Nakabeppu, Y., Behmanesh, M., Yamaguchi, H., Yoshimura, D., Sakumi, K., Prevention of the mutagnecity and cytotoxicity of oxidized purine nucleotides. Evans, M.D., Cooke, M.S., (eds.) Oxidative Damage to Nucleic Acids, 2007, Landes Bioscience and Springer Science+Business Media, Austin,Tx; New York, NY, USA, 40–53.
78. Nakabeppu, Y., Tsuchimoto, D., Yamaguchi, H., Sakumi, K., Oxidative damage in nucleic acids and Parkinson's disease. J. Neurosci. Res. 85 (2007), 919–934.
79. Nakabeppu, Y., Molecular genetics and structural biology of human MutT homolog, MTH1. Mutat. Res. 477 (2001), 59–70.
80. Nakabeppu, Y., Regulation of intracellular localization of human MTH1, OGG1, and MYH proteins for repair of oxidative DNA damage. Prog. Nucleic Acid Res. Mol. Biol. 68 (2001), 75–94.
81. Nakabeppu, Y., Cellular levels of 8-oxoguanine in either DNA or the nucleotide pool play pivotal roles in carcinogenesis and survival of cancer cells. Int. J. Mol. Sci. 15 (2014), 12543–12557.
82. Newman, L.A., Korol, D.L., Gold, P.E., Lactate produced by glycogenolysis in astrocytes regulates memory processing. PLoS One, 6, 2011, e28427.
83. Nishioka, K., Ohtsubo, T., Oda, H., Fujiwara, T., Kang, D., Sugimachi, K., Nakabeppu, Y., Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol. Biol. Cell 10 (1999), 1637–1652.
84. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E.K., Jones, P.K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C.S., Petersen, R.B., Smith, M.A., Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001), 759–767.
85. Ohara, T., Doi, Y., Ninomiya, T., Hirakawa, Y., Hata, J., Iwaki, T., Kanba, S., Kiyohara, Y., Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 77 (2011), 1126–1134.
86. Ohno, M., Sakumi, K., Fukumura, R., Furuichi, M., Iwasaki, Y., Hokama, M., Ikemura, T., Tsuzuki, T., Gondo, Y., Nakabeppu, Y., 8-Oxoguanine causes spontaneous de novo germline mutations in mice. Sci. Rep., 4, 2014, 4689.
87. Ohtsubo, T., Nishioka, K., Imaiso, Y., Iwai, S., Shimokawa, H., Oda, H., Fujiwara, T., Nakabeppu, Y., Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res. 28 (2000), 1355–1364.
88. Oka, S., Nakabeppu, Y., DNA glycosylase encoded by MUTYH functions as a molecular switch for programmed cell death under oxidative stress to suppress tumorigenesis. Cancer Sci. 102 (2011), 677–682.
89. Oka, S., Ohno, M., Tsuchimoto, D., Sakumi, K., Furuichi, M., Nakabeppu, Y., Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J. 27 (2008), 421–432.
90. Parachikova, A., Agadjanyan, M.G., Cribbs, D.H., Blurton-Jones, M., Perreau, V., Rogers, J., Beach, T.G., Cotman, C.W., Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol. Aging 28 (2007), 1821–1833.
91. Pifferi, F., Jouin, M., Alessandri, J.M., Haedke, U., Roux, F., Perriere, N., Denis, I., Lavialle, M., Guesnet, P., n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. Prostaglandins Leukot. Essent. Fatty Acids 77 (2007), 279–286.
92. Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., Ferri, C.P., The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement, 9(63–75), 2013, e2.
93. Puzzo, D., Gulisano, W., Palmeri, A., Arancio, O., Rodent models for Alzheimer's disease drug discovery. Expert Opin. Drug Discov. 10 (2015), 703–711.
94. Querfurth, H.W., LaFerla, F.M., Alzheimer's disease. N. Engl. J. Med. 362 (2010), 329–344.
95. Saito, K., Elce, J.S., Hamos, J.E., Nixon, R.A., Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 2628–2632.
96. Schechter, R., Whitmire, J., Holtzclaw, L., George, M., Harlow, R., Devaskar, S.U., Developmental regulation of insulin in the mammalian central nervous system. Brain Res. 582 (1992), 27–37.
97. Seidah, N.G., Benjannet, S., Hamelin, J., Mamarbachi, A.M., Basak, A., Marcinkiewicz, J., Mbikay, M., Chretien, M., Marcinkiewicz, M., The subtilisin/kexin family of precursor convertases. Emphasis on PC1 PC2/7B2. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Ann. N. Y. Acad. Sci. 885 (1999), 57–74.
98. Sekita, A., Ninomiya, T., Tanizaki, Y., Doi, Y., Hata, J., Yonemoto, K., Arima, H., Sasaki, K., Iida, M., Iwaki, T., Kanba, S., Kiyohara, Y., Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr. Scand. 122 (2010), 319–325.
99. Shao, C., Xiong, S., Li, G.M., Gu, L., Mao, G., Markesbery, W.R., Lovell, M.A., Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain. Free Radic. Biol. Med. 45 (2008), 813–819.
100. Sheng, Z., Oka, S., Tsuchimoto, D., Abolhassani, N., Nomaru, H., Sakumi, K., Yamada, H., Nakabeppu, Y., 8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair. J. Clin. Invest. 122 (2012), 4344–4361.
101. Sinha, S., Anderson, J.P., Barbour, R., Basi, G.S., Caccavello, R., Davis, D., Doan, M., Dovey, H.F., Frigon, N., Hong, J., Jacobson-Croak, K., Jewett, N., Keim, P., Knops, J., Lieberburg, I., Power, M., Tan, H., Tatsuno, G., Tung, J., Schenk, D., Seubert, P., Suomensaari, S.M., Wang, S., Walker, D., Zhao, J., McConlogue, L., John, V., Purification and cloning of amyloid precursor protein b-secretase from human brain. Nature 402 (1999), 537–540.
102. Sleigh, A., Raymond-Barker, P., Thackray, K., Porter, D., Hatunic, M., Vottero, A., Burren, C., Mitchell, C., McIntyre, M., Brage, S., Carpenter, T.A., Murgatroyd, P.R., Brindle, K.M., Kemp, G.J., O'Rahilly, S., Semple, R.K., Savage, D.B., Mitochondrial dysfunction in patients with primary congenital insulin resistance. J. Clin. Invest. 121 (2011), 2457–2461.
103. Song, X.N., Zhang, L.Q., Liu, D.G., Lin, J., Zheng, J.D., Dai, D.P., Hei, A.L., Hayakawa, H., Sekiguchi, M., Cai, J.P., Oxidative damage to RNA and expression patterns of MTH1 in the hippocampi of senescence-accelerated SAMP8 mice and Alzheimer's disease patients. Neurochem. Res. 36 (2011), 1558–1565.
104. Sosa-Ortiz, A.L., Acosta-Castillo, I., Prince, M.J., Epidemiology of dementias and Alzheimer's disease. Arch. Med. Res. 43 (2012), 600–608.
105. Stobart, J.L., Anderson, C.M., Multifunctional role of astrocytes as gatekeepers of neuronal energy supply. Front. Cell. Neurosci., 7, 2013, 38.
106. Stockhorst, U., de Fries, D., Steingrueber, H.J., Scherbaum, W.A., Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Physiol. Behav. 83 (2004), 47–54.
107. Suzuki, A., Stern, S.A., Bozdagi, O., Huntley, G.W., Walker, R.H., Magistretti, P.J., Alberini, C.M., Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144 (2011), 810–823.
108. Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G., Iwatsubo, T., The role of presenilin cofactors in the g-secretase complex. Nature 422 (2003), 438–441.
109. Tan, M.G., Chua, W.T., Esiri, M.M., Smith, A.D., Vinters, H.V., Lai, M.K., Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease. J. Neurosci. Res. 88 (2010), 1157–1169.
110. Uittenbogaard, M., Baxter, K.K., Chiaramello, A., The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass. ASN Neuro, 2, 2010, e00034.
111. Ventura, I., Russo, M.T., De Nuccio, C., De Luca, G., Degan, P., Bernardo, A., Visentin, S., Minghetti, L., Bignami, M., hMTH1 expression protects mitochondria from Huntington's disease-like impairment. Neurobiol. Dis. 49 (2013), 148–158.
112. van der Horst, A., Burgering, B.M., Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8 (2007), 440–450.
113. Wang, J., Xiong, S., Xie, C., Markesbery, W.R., Lovell, M.A., Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J. Neurochem. 93 (2005), 953–962.
114. Wang, J., Markesbery, W.R., Lovell, M.A., Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J. Neurochem. 96 (2006), 825–832.
115. Wood, I.S., Trayhurn, P., Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br. J. Nutr. 89 (2003), 3–9.
116. WHO, 2015. Dementia. http://www.who.int/mediacentre/factsheets/fs362/en (accessed 16.02.16).
117. Xiong, H., Callaghan, D., Wodzinska, J., Xu, J., Premyslova, M., Liu, Q.Y., Connelly, J., Zhang, W., Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease. Neurosci. Bull. 27 (2011), 221–232.
118. Yamaguchi, H., Kajitani, K., Dan, Y., Furuichi, M., Ohno, M., Sakumi, K., Kang, D., Nakabeppu, Y., MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Cell Death Differ. 13 (2006), 551–563.
119. Yamashima, T., Reconsider Alzheimer's disease by the ‘calpain-cathepsin hypothesis’—a perspective review. Prog. Neurobiol. 105 (2013), 1–23.